Doctors and patients weigh in: what matters most in lung cancer care?
NCT ID NCT06448793
Summary
This study aims to understand what patients and their doctors value most when choosing treatments for early-stage, operable lung cancer. Researchers will conduct short interviews with 55 patients and physicians from the US, Germany, and Japan. The goal is to gather insights to help shape future treatment options and decision-making.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Evidera
RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.